CDKN2A and melanoma: Using the RCAS/Dct:TVA mouse model of melanoma, we found that gain-of-function MEK1 mutations (V60E, C121S and GF) are capable of transforming melanoma cells in vitro and driving high-grade melanoma in the context of Cdkn2a and Pten loss.